BP
BioCryst Pharmaceuticals Inc
🇩🇪XSTU.BO1GermanyHealthcare
€7.00EURdown -0.12 (-1.69%)ClosedEnd of day9:48 PM
Price€7.00-0.12 (-1.69%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US09058V1035
- CUSIP
- Not reported
Company
- Employees
- 435
- Headquarters
- Durham, United States
- Website
- https://www.biocryst.com
- CEO
- Mr. Charles K. Gayer
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $940.61M+68.72%up year on year
- Net income
- -$384.67M-977.18%down year on year
- Gross margin
- 23.52%-75.76%down year on year
- Free cash flow
- $357.11M+2,165.77%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.